SpaceX is expected to secure index entry in the coming days and weeks, unlocking a new source of investor demand after there’s been “striking” breadth so far.

AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report.

“If you find a need in your community, there’s likely an organization that will help you get involved.”

Despite a growing pool of research talent, not many have the experience of building and scaling AI, experts say.

A flurry of headlines on Friday point to an increasingly fragile deal between the U.S. and Iran.

The health damage of loneliness is similar to heavy smoking and obesity

The SOXX’s RSI indicator has fallen further below the overbought threshold despite prices making record highs. History suggests that’s a bad sign.

“Partly due to some mental-health issues, they may continue to go through life living paycheck to paycheck, or worse.”

Trading of ordinary shares in the French technology company have been suspended following allegations from a short seller.

Kevin Warsh is forcing Wall Street to do the heavy lifting. Use these benchmarks to find your footing.

A job loss is devastating at any age. After 50, it can completely shatter your finances.

Written off after the rise of Anthropic’s Claude Code, Cursor now looks to reclaim its crown as a vibe-coding heavyweight with SpaceX’s backing

Interest rate differentials, growth prospects, demand for capital from AI investment and bumper stock market issuance is generating demand for the dollar and a bullish impulse

During his first press conference as Fed chair Wednesday, Kevin Warsh repeated one refrain in his answers to many reporters’ questions: A task force is looking into it.

Strategists at the investment bank see gold rising to $4,900 a tonne by the end of the year instead of $5,400.

This pro-level move minimizes out-of-pocket costs and helps manage risk.

The U.S. dollar headed Thursday for its highest close in more than a year, as investors continued to digest the Federal Reserve’s Wednesday meeting, which revived the possibility of further interest-rate increases.

Some of the AI boom’s biggest earners have become its biggest bargains.

Global oil prices on Thursday touched their lowest level since the U.S.-Israeli war with Iran began almost four months ago. That marks a drop of more than 30% from their May peak and likely averts the disaster commodity experts had warned about as one of the largest crude supply shortages in history began playing out.

Midjourney is making a foray into healthcare with its latest body-scanner product, aiming to make medical imaging more accessible.

College students with any sort of work experience are twice as likely to be employed shortly after graduating.

Their descendants, and the rest of us, are still paying the price.

A string of surprise hits has this year’s box office already up 15% from last year, but studios and theater owners are looking to Pixar’s signature franchise to deliver a big boost.

People are still holding back on participating in Roth plans at work, Vanguard says.

As Tesla has doubled down on artificial intelligence, investors are left trying to make sense of the company’s progress. According to analysts at Oppenheimer, tracking how Tesla spends its cash may provide some insight.